Evidence map›Paper›PMID 31786140›Full record

ArticleCancer cell2019

HOTTIP lncRNA Promotes Hematopoietic Stem Cell Self-Renewal Leading to AML-like Disease in Mice.

Huacheng Luo, Ganqian Zhu, Jianfeng Xu, Qian Lai, Bowen Yan, Ying Guo, Tsz Kan Fung, Bernd B Zeisig, Ya Cui, Jie Zha and 9 more

Open access · bronzeAbstract read
In one paragraph

Article in Cancer cell, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 124 papers.

0numbers the graph read from it
0cells of the map it votes in
124citing papers in PubMed
8.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

124 citing papers in PubMed, 210 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Mechanistic study of antisense long non-coding RNAExploration of targeted anti-tumor therapy · 2026
    Article
  10. Article
  11. Review
  12. Lack of association betweenTranslational pediatrics · 2025
    Article
  13. Rewiring cancer epigenome: lncRNA as modulator of chromatin architecture and neoplastic transformation.Mammalian genome : official journal of the International Mammalian Genome Society · 2025
    Review
  14. CRISPRi Screen Identifies a Novel Growth Suppressor lncRNA,bioRxiv : the preprint server for biology · 2025
    Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article

64 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 10 institutions in 3 countries.

Huacheng LuoDivision of Pediatric Hematology/Oncology, Department of Pediatrics, Pennsylvania State University College of Medicine, Hershey, PA 17033, USA.
Ganqian ZhuDepartment of Molecular Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA; Department of Biochemistry and Molecular Biology, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL 33136.
Jianfeng XuDepartment of Molecular and Cellular Biology, Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA.
Qian LaiDivision of Pediatric Hematology/Oncology, Department of Pediatrics, Pennsylvania State University College of Medicine, Hershey, PA 17033, USA; Department of Hematology, The First Affiliated Hospital of Xiamen University, Xiamen 361003, China.
Bowen YanDepartment of Anatomy and Cell Biology, University of Florida College of Medicine, Gainesville, FL 32610, USA.
Ying GuoDepartment of Biochemistry and Molecular Biology, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL 33136; Department of Cell System & Anatomy, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.
Tsz Kan FungSchool of Cancer and Pharmaceutical Science, King's College London, London SE5 9NU, UK.
Bernd B ZeisigSchool of Cancer and Pharmaceutical Science, King's College London, London SE5 9NU, UK.
Ya CuiDepartment of Molecular and Cellular Biology, Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA; Department of Biological Chemistry, University of California Irvine, Irvine, CA 92697, USA.
Jie ZhaDepartment of Hematology, The First Affiliated Hospital of Xiamen University, Xiamen 361003, China.
Christopher CogleDivision of Hematology/Oncology, Department of Medicine, University of Florida College of Medicine, Gainesville, FL 32610, USA.
Fei WangDepartment of Hematology and Oncology, The Affiliated Zhongda Hospital, Southeast University Medical School, Nanjing 210009, China.
Bing XuDepartment of Hematology, The First Affiliated Hospital of Xiamen University, Xiamen 361003, China.
Feng-Chun YangDepartment of Biochemistry and Molecular Biology, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL 33136; Department of Cell System & Anatomy, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA; Mays Cancer Center, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.
Wei LiDepartment of Molecular and Cellular Biology, Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA; Department of Biological Chemistry, University of California Irvine, Irvine, CA 92697, USA.
Chi Wai Eric SoSchool of Cancer and Pharmaceutical Science, King's College London, London SE5 9NU, UK. Electronic address: eric.so@kcl.ac.uk.
Yi QiuDepartment of Anatomy and Cell Biology, University of Florida College of Medicine, Gainesville, FL 32610, USA. Electronic address: qiuy@ufl.edu.
Mingjiang XuDepartment of Molecular Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA; Department of Biochemistry and Molecular Biology, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL 33136; Mays Cancer Center, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA. Electronic address: xum1@uthscsa.edu.
Suming HuangDivision of Pediatric Hematology/Oncology, Department of Pediatrics, Pennsylvania State University College of Medicine, Hershey, PA 17033, USA; Penn State Cancer Institute, Pennsylvania State University College of Medicine, Hershey, PA 17033, USA. Electronic address: shuang4@pennstatehealth.psu.edu.
First Affiliated Hospital of Xiamen University · CNKing's College London · GBBaylor College of Medicine · USPennsylvania State University · USThe University of Texas Health Science Center at San Antonio · USUniversity of Florida · USUniversity of Miami · USFlorida College · USUniversity of California, Irvine · USZhongda Hospital Southeast University · CN

Funding

Role of Asxl1 in normal hematopoiesis and pathogenesis of myeloid malignanciesR01CA172408 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI XU, MINGJIANG, YANG, FENG-CHUN · 2014 to 2024
$3.4M
Transfer: DNA Methylation Canyons in Human Cancers: Methods, Target Genes and Functional ConsequencesR01CA228140 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI LI, WEI · 2019 to 2023
$2.8M
Roles of TET2-dependent DNA demethylation intermediates in hematological malignanciesR01HL145883 · NHLBI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI XU, MINGJIANG, YANG, FENG-CHUN · 2019 to 2022
$2.2M
Role of lincRNAs in HSC function and leukemogenesisR01HL141950 · NHLBI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI HUANG, SUMING, XU, MINGJIANG · 2019 to 2022
$2.2M
Computational and Experimental Modeling of Epigenetic DNA MethylationR01HG007538 · NHGRI · UNIVERSITY OF CALIFORNIA-IRVINE · PI LI, WEI · 2014 to 2018
$1.9M
Regulation of TAL1/SCL in T-Cell LeukemiaR01CA204044 · NCI · UNIVERSITY OF FLORIDA · PI HUANG, SUMING · 2017 to 2021
$1.6M
Epigenetic regulation of hematopoiesisR01HL144712 · NHLBI · UNIVERSITY OF FLORIDA · PI QIU, YI · 2019 to 2022
$1.6M
The Role of Long Noncoding RNA in HematopoiesisR01DK110108 · NIDDK · UNIVERSITY OF FLORIDA · PI HUANG, SUMING · 2016 to 2019
$1.3M
Cancer Research UK 16753Medical Research Council G0800892NCI NIH HHS R01 CA172408NCI NIH HHS R01 CA204044NCI NIH HHS R01 CA228140NHGRI NIH HHS R01 HG007538NHLBI NIH HHS R01 HL141950NHLBI NIH HHS R01 HL144712NHLBI NIH HHS R01 HL145883NIDDK NIH HHS R01 DK110108
6 · The paper itself

Abstract

Long non-coding RNAs (lncRNAs) are critical for regulating HOX genes, aberration of which is a dominant mechanism for leukemic transformation. How HOX gene-associated lncRNAs regulate hematopoietic stem cell (HSC) function and contribute to leukemogenesis remains elusive. We found that HOTTIP is aberrantly activated in acute myeloid leukemia (AML) to alter HOXA-driven topologically associated domain (TAD) and gene expression. HOTTIP loss attenuates leukemogenesis of transplanted mice, while reactivation of HOTTIP restores leukemic TADs, transcription, and leukemogenesis in the CTCF-boundary-attenuated AML cells. Hottip aberration in mice abnormally promotes HSC self-renewal leading to AML-like disease by altering the homeotic/hematopoietic gene-associated chromatin signature and transcription program. Hottip aberration acts as an oncogenic event to perturb HSC function by reprogramming leukemic-associated chromatin and gene transcription.

Indexed as

AnimalsCell ProliferationCell Self RenewalChromatinGene Expression Regulation, LeukemicGene Knockdown TechniquesHematopoietic Stem CellsHomeodomain ProteinsLeukemia, Myeloid, AcuteMiceRNA, Long NoncodingChromatinHomeodomain Proteinslong noncoding RNA HOTTIP, humanRNA, Long Noncodingchromatin domainCTCF boundaryenhancer/promoter accessibilityHOTTIP lncRNAHOTTIP transgenic miceHOX and hematopoietic gene regulationHSC self-renewalleukemiaWNT signaling targets

Identifiers

PMID31786140
PMCPMC6917035
OpenAlexW2904407571

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.